Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
The macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either locali...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3893214?pdf=render |
id |
doaj-c4d502fea09a40baab3033767d962e38 |
---|---|
record_format |
Article |
spelling |
doaj-c4d502fea09a40baab3033767d962e382020-11-25T00:23:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8536110.1371/journal.pone.0085361Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.Marian SeifMichael L ImpelidoMichael G AppsNial J WheateThe macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6]uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.http://europepmc.org/articles/PMC3893214?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marian Seif Michael L Impelido Michael G Apps Nial J Wheate |
spellingShingle |
Marian Seif Michael L Impelido Michael G Apps Nial J Wheate Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. PLoS ONE |
author_facet |
Marian Seif Michael L Impelido Michael G Apps Nial J Wheate |
author_sort |
Marian Seif |
title |
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
title_short |
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
title_full |
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
title_fullStr |
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
title_full_unstemmed |
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
title_sort |
topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
The macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6]uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery. |
url |
http://europepmc.org/articles/PMC3893214?pdf=render |
work_keys_str_mv |
AT marianseif topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril AT michaellimpelido topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril AT michaelgapps topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril AT nialjwheate topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril |
_version_ |
1725357191969374208 |